April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Genprex (GNPX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 22, 2025 (04:43)
Sector: HealthcareThe share price of Genprex, Inc. (GNPX) now
Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2025, 2026, 2027. How much will one Genprex share be worth in 2025 - 2027?
When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.
Historical and forecast chart of Genprex stock
The chart below shows the historical price of Genprex stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.
Long-term forecasts by years.
Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).
Genprex daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 24 | 0.35 | 0.32 | 0.37 | 15.18 |
| May 25 | 0.36 | 0.33 | 0.37 | 14.57 |
| May 26 | 0.35 | 0.33 | 0.38 | 17.17 |
| May 27 | 0.35 | 0.33 | 0.38 | 14.63 |
| May 28 | 0.40 | 0.38 | 0.43 | 12.57 |
| May 29 | 0.39 | 0.37 | 0.43 | 15.95 |
| May 30 | 0.41 | 0.37 | 0.44 | 20.58 |
| May 31 | 0.41 | 0.38 | 0.44 | 14.45 |
| Jun 01 | 0.45 | 0.41 | 0.49 | 18.72 |
| Jun 02 | 0.41 | 0.39 | 0.43 | 9.00 |
| Jun 03 | 0.36 | 0.35 | 0.39 | 12.53 |
| Jun 04 | 0.40 | 0.36 | 0.43 | 19.19 |
| Jun 05 | 0.39 | 0.36 | 0.44 | 21.71 |
| Jun 06 | 0.44 | 0.41 | 0.47 | 13.57 |
| Jun 07 | 0.49 | 0.46 | 0.54 | 19.33 |
| Jun 08 | 0.49 | 0.45 | 0.54 | 19.95 |
| Jun 09 | 0.56 | 0.54 | 0.60 | 11.13 |
| Jun 10 | 0.62 | 0.59 | 0.67 | 13.84 |
| Jun 11 | 0.54 | 0.51 | 0.56 | 9.17 |
| Jun 12 | 0.52 | 0.49 | 0.56 | 16.25 |
| Jun 13 | 0.49 | 0.46 | 0.52 | 13.59 |
| Jun 14 | 0.46 | 0.40 | 0.47 | 17.56 |
| Jun 15 | 0.50 | 0.44 | 0.53 | 19.88 |
| Jun 16 | 0.51 | 0.45 | 0.56 | 24.05 |
| Jun 17 | 0.51 | 0.47 | 0.57 | 20.31 |
| Jun 18 | 0.50 | 0.48 | 0.54 | 12.84 |
| Jun 19 | 0.50 | 0.48 | 0.54 | 14.34 |
| Jun 20 | 0.48 | 0.45 | 0.53 | 17.16 |
| Jun 21 | 0.48 | 0.46 | 0.54 | 16.49 |
| Jun 22 | 0.45 | 0.41 | 0.46 | 13.45 |
Genprex Daily Price Targets
Genprex Stock Forecast 05-24-2025.
Forecast target price for 05-24-2025: $0.35.
Positive dynamics for Genprex shares will prevail with possible volatility of 13.176%.
Pessimistic target level: 0.32
Optimistic target level: 0.37
Genprex Stock Forecast 05-25-2025.
Forecast target price for 05-25-2025: $0.36.
Positive dynamics for Genprex shares will prevail with possible volatility of 12.720%.
Pessimistic target level: 0.33
Optimistic target level: 0.37
Genprex Stock Forecast 05-26-2025.
Forecast target price for 05-26-2025: $0.35.
Negative dynamics for Genprex shares will prevail with possible volatility of 14.657%.
Pessimistic target level: 0.33
Optimistic target level: 0.38
Genprex Stock Forecast 05-27-2025.
Forecast target price for 05-27-2025: $0.35.
Positive dynamics for Genprex shares will prevail with possible volatility of 12.760%.
Pessimistic target level: 0.33
Optimistic target level: 0.38
Genprex Stock Forecast 05-28-2025.
Forecast target price for 05-28-2025: $0.40.
Positive dynamics for Genprex shares will prevail with possible volatility of 11.163%.
Pessimistic target level: 0.38
Optimistic target level: 0.43
Genprex Stock Forecast 05-29-2025.
Forecast target price for 05-29-2025: $0.39.
Negative dynamics for Genprex shares will prevail with possible volatility of 13.753%.
Pessimistic target level: 0.37
Optimistic target level: 0.43
GNPX (GNPX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 0.28 | 0.22 | 0.39 | 44.20 |
| Jul. | 0.22 | 0.15 | 0.25 | 37.55 |
| Aug. | 0.16 | 0.12 | 0.23 | 46.07 |
| Sep. | 0.09 | 0.08 | 0.13 | 42.03 |
| Oct. | 0.10 | 0.07 | 0.14 | 49.09 |
| Nov. | 0.11 | 0.08 | 0.14 | 42.97 |
| Dec. | 0.16 | 0.10 | 0.21 | 50.78 |
Genprex forecast for this year
Genprex Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $0.27945. Pessimistic: $0.22. Optimistic: $0.39
Genprex Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $0.215176. Pessimistic: $0.15. Optimistic: $0.25
Genprex Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $0.163534. Pessimistic: $0.12. Optimistic: $0.23
Genprex Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $0.0940321. Pessimistic: $0.08. Optimistic: $0.13
Genprex Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $0.104846. Pessimistic: $0.07. Optimistic: $0.14
Genprex Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $0.110088. Pessimistic: $0.08. Optimistic: $0.14
Genprex Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $0.160178. Pessimistic: $0.10. Optimistic: $0.21
Genprex (GNPX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.14 | 0.10 | 0.17 | 40.93 |
| Feb | 0.17 | 0.12 | 0.20 | 38.46 |
| Mar | 0.18 | 0.16 | 0.21 | 25.42 |
| Apr | 0.21 | 0.15 | 0.23 | 34.55 |
| May | 0.24 | 0.18 | 0.30 | 39.60 |
| Jun | 0.25 | 0.16 | 0.31 | 46.53 |
| Jul | 0.28 | 0.19 | 0.37 | 48.50 |
| Aug | 0.33 | 0.25 | 0.46 | 45.65 |
| Sep | 0.48 | 0.40 | 0.63 | 35.98 |
| Oct | 0.46 | 0.29 | 0.61 | 52.45 |
| Nov | 0.52 | 0.45 | 0.60 | 25.64 |
| Dec | 0.69 | 0.51 | 0.89 | 42.86 |
Genprex (GNPX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.78 | 0.70 | 1.00 | 30.23 |
| Feb | 0.57 | 0.45 | 0.73 | 38.28 |
| Mar | 0.64 | 0.45 | 0.87 | 47.97 |
| Apr | 0.80 | 0.59 | 0.90 | 34.96 |
| May | 0.84 | 0.62 | 1.03 | 39.84 |
| Jun | 1.09 | 0.97 | 1.26 | 22.84 |
| Jul | 1.19 | 1.02 | 1.37 | 25.33 |
| Aug | 1.27 | 1.13 | 1.74 | 35.40 |
| Sep | 0.72 | 0.48 | 0.82 | 41.67 |
| Oct | 0.88 | 0.65 | 1.04 | 37.71 |
| Nov | 0.54 | 0.34 | 0.71 | 52.63 |
| Dec | 0.59 | 0.37 | 0.66 | 43.05 |
Genprex information and performance
100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US
Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.
EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Genprex Stock)
Should I Buy Genprex Shares in 2025 year?
Does Genprex pay dividends?
Which economic sector do Genprex's shares belong to?
Which other securities belong to the same sector as Genprex's shares?
